|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 42070 |
FusionGeneSummary for WRAP53_SLC44A2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: WRAP53_SLC44A2 | Fusion gene ID: 42070 | Hgene | Tgene | Gene symbol | WRAP53 | SLC44A2 | Gene ID | 55135 | 57153 |
| Gene name | WD repeat containing antisense to TP53 | solute carrier family 44 member 2 | |
| Synonyms | DKCB3|TCAB1|WDR79 | CTL2|PP1292 | |
| Cytomap | 17p13.1 | 19p13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | telomerase Cajal body protein 1WD repeat-containing protein 79WD repeat-containing protein WRAP53WD40 protein Wrap53WD40 repeat-containing protein antisense to TP53WD40 repeat-containing protein encoding RNA antisense to p53 | choline transporter-like protein 2solute carrier family 44 (choline transporter), member 2testicular tissue protein Li 47 | |
| Modification date | 20180519 | 20180525 | |
| UniProtAcc | Q9BUR4 | Q8IWA5 | |
| Ensembl transtripts involved in fusion gene | ENST00000431639, ENST00000316024, ENST00000457584, ENST00000396463, ENST00000534050, | ENST00000407327, ENST00000335757, ENST00000586078, ENST00000588214, | |
| Fusion gene scores | * DoF score | 4 X 3 X 4=48 | 5 X 5 X 7=175 |
| # samples | 4 | 10 | |
| ** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/175*10)=-0.807354922057604 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: WRAP53 [Title/Abstract] AND SLC44A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | WRAP53 | GO:0007004 | telomere maintenance via telomerase | 23685356 |
| Hgene | WRAP53 | GO:0051973 | positive regulation of telomerase activity | 19179534|23685356 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-AR-A256-01A | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000431639 | ENST00000407327 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000431639 | ENST00000335757 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000431639 | ENST00000586078 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| 5CDS-intron | ENST00000431639 | ENST00000588214 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000316024 | ENST00000407327 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000316024 | ENST00000335757 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000316024 | ENST00000586078 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| 5CDS-intron | ENST00000316024 | ENST00000588214 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000457584 | ENST00000407327 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000457584 | ENST00000335757 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000457584 | ENST00000586078 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| 5CDS-intron | ENST00000457584 | ENST00000588214 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000396463 | ENST00000407327 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000396463 | ENST00000335757 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| Frame-shift | ENST00000396463 | ENST00000586078 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| 5CDS-intron | ENST00000396463 | ENST00000588214 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| intron-3CDS | ENST00000534050 | ENST00000407327 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| intron-3CDS | ENST00000534050 | ENST00000335757 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| intron-3CDS | ENST00000534050 | ENST00000586078 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
| intron-intron | ENST00000534050 | ENST00000588214 | WRAP53 | chr17 | 7592640 | + | SLC44A2 | chr19 | 10746999 | + |
Top |
FusionProtFeatures for WRAP53_SLC44A2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| WRAP53 | SLC44A2 |
| Essential component of the telomerase holoenzymecomplex, a ribonucleoprotein complex essential for the replicationof chromosome termini that elongates telomeres in most eukaryotes.In the telomerase holoenzyme complex, it controls telomeraselocalization to Cajal body. Required for delivery of TERC totelomeres during S phase and for telomerase activity. Binds smallCajal body RNAs (scaRNAs). The mRNA encoding this protein plays acritical role in the regulation of p53 expression at the post-transcriptional level; it is involved both in maintaining basalp53 mRNA levels and in p53 induction upon DNA damage.{ECO:0000269|PubMed:19179534, ECO:0000269|PubMed:19250907}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for WRAP53_SLC44A2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for WRAP53_SLC44A2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| WRAP53 | PRPF4, PTGES3, XPC, WAPAL, SNRPC, USP11, TNPO1, RBBP7, GAR1, FAM43A, MDC1, RNF8, H2AFX, HNRNPU, ZFHX3, CCT6A, DKC1, MYBPH, NDUFV3, TCP1, CCT3, STK24, CCT7, CCT4, CCT2, CCT8, CCT5, PRPF38B, PTPN1, RAP1B, RXRB, POLG2, CNTROB, MRPL14, KIAA1683, LYPD4, CRYL1, ARHGAP25, FAM46A | SLC44A2 | RP2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for WRAP53_SLC44A2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for WRAP53_SLC44A2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | WRAP53 | C3151442 | DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3 | 1 | UNIPROT |
| Tgene | SLC44A2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|